4 completed, 2 recruiting, 2 terminated. 4 Phase 1, 2 Not applicable, 1 Early Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Terminated 2, Completed 1, Recruiting 1 |
| Not applicable | 2 | Completed 2 |
| Early Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Gitte Moos Knudsen: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Precision Medicine in the Treatment of Epilepsy Levetiracetam, Levetiracetam Tablets, Lamotrigine tablet - Epilepsy | Recruiting | Gitte Moos Knudsen | 550 | 2022-02-18 | 2024-04-11 | |
| Prophylactic Effects of Psilocybin on Chronic Cluster Headache Psilocybin - Cluster Headache | Phase 1 / Phase 2 | Terminated | Gitte Moos Knudsen | 10 | 2020-01-21 | 2022-08-10 |
| Effects of Sleep Deprivation and Adrenergic Inhibition on Glymphatic Flow in Humans Carvedilol 25mg, Placebo oral capsule - Sleep Deprivation, Sleep Wake Disorders | Early Phase 1 | Completed | Gitte Moos Knudsen | 22 | 2018-08-28 | 2022-11-23 |
| The Neurobiological Effect of 5-HT2AR Modulation Psilocybine, Ketanserin - Basic Science | Phase 1 | Recruiting | Gitte Moos Knudsen | 200 | 2017-03-03 | 2024-12-16 |
| Cerebral Pharmacodynamic Effects of 5-HT1B Receptor Stimulation Sumatriptan - Healthy Volunteers | Phase 1 | Terminated | Gitte Moos Knudsen | 17 | 2016-09-01 | 2019-06-27 |
| [11C]Cimbi-36 Dosimetry [11C]Cimbi-36, [11C]Cimbi-36-5 - Healthy | Phase 1 | Completed | Gitte Moos Knudsen | 8 | 2015-12-01 | 2019-03-26 |
| Evaluation of [11C]Cimbi-36 as an Agonist PET Radioligand for Imaging of 5-HT2A Receptors Citalopram and Pindolol, Placebo, Acute tryptophan depletion - Healthy | Not applicable | Completed | Gitte Moos Knudsen | 24 | 2013-01-01 | 2025-02-20 |
| Neuropsychobiological Correlates of Sex-steroid Hormone Manipulation in Healthy Women: a Risk Model for Depression Goserelin 3.6 mg implant, Placebo - Postpartum Depression, Major Depressive Disorder | Not applicable | Completed | Gitte Moos Knudsen | 63 | 2011-01-01 | 2016-01-22 |
Cluster Headache (1) · Coitus (1) · Depression, Postpartum (1) · Depressive Disorder, Major (1) · Epilepsy (1) · Nerve Degeneration (1) · Psychological Well-Being (1) · Schizophrenia (1) · Sleep Deprivation (1) · Sleep Wake Disorders (1)
Psilocybin (2) · Carvedilol (1) · Cimbi-36 (1) · Citalopram (1) · Drug Implants (1) · Goserelin (1) · Ketanserin (1) · Lamotrigine (1) · Levetiracetam (1) · Pindolol (1) · Sodium Chloride (1) · Sumatriptan (1) · Tryptophan (1)
Denmark (8)
Gitte M Knudsen, MD, DMSc (2) · Gitte M Knudsen, DMSc (1) · Gitte M Knudsen, Professor (1) · Lars Hageman Pinborg, MD (1) · Sebastian C Sebastian, PhD (1) · Vibe G Frokjaer, MD, Phd (1)
PMID 27649641, PMID 31099405, PMID 38758370, PMID 40655979, PMID 41264592, PMID 42212900, PMID 42457666